Zb. You et al., THE STRIATONIGRAL DYNORPHIN PATHWAY OF THE RAT STUDIED WITH IN-VIVO MICRODIALYSIS .2. EFFECTS OF DOPAMINE D-1 AND D-2 RECEPTOR AGONISTS, Neuroscience, 63(2), 1994, pp. 427-434
In vivo microdialysis was used to study the effect of intracerebral ad
ministration of dopamine agonists on dynorphin B release in the striat
um and substantia nigra of rats. The release of dopamine and GABA was
also investigated. Administration of the dopamine D-1 agonist SKF 3839
3 (10-100 mu M) into the striatum increased extracellular dynorphin B
and GABA levels in the ipsilateral substantia nigra, in a concentratio
n-dependent manner. After a short-lasting increase, nigral dopamine le
vels were significantly decreased after the highest concentration of s
triatal SKF 38393. An increase in striatal dynorphin B, GABA and dopam
ine levels was also observed. When SKF 38393 (10 mu M) was administere
d into the substantia nigra, nigral dynorphin B and GABA, but not dopa
mine levels increased. No significant effects were observed on striata
l levels. Administration of the dopamine D-2 agonist, quinpirole (100
mu M), into the striatum decreased dopamine levels in both striatum an
d substantia nigra, while no effect was observed on striatal or nigral
dynorphin B and GABA levels. Quinpirole (10-100 mu M) given into the
substantia nigra, decreased striatal dopamine levels in a concentratio
n manner. In the nigra, a short-lasting increase in dopamine levels wa
s observed following the highest concentration of nigral quinpirole (1
00 mu M). The effect was followed by a decrease in dopamine levels. No
significant effects were observed on striatal or nigral dynorphin B a
nd GABA levels. The results show that stimulation of D-1 receptors in
striatum and substantia nigra leads to activation of the striatonigral
dynorphin pathway. A parallel effect could also be seen on nigral GAB
A release. In contrast, D-2 receptor stimulation primarily leads to in
hibition of the nigrostriatal dopamine pathway, probably via autorecep
tors located on striatal dopamine terminals and on nigral dopamine den
drites.